Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;29(8):4311-4318.
doi: 10.1007/s00520-020-05898-9. Epub 2021 Jan 7.

Assessment of an onco-sexology support and follow-up program in cervical or vaginal cancer patients undergoing brachytherapy

Marce-Amara Kpoghomou  1 , Marion Geneau  2 , Josiane Menard  2 , Moufid Stiti  3 , Thierry Almont  4   5 , Bishwajit Ghose  6 , Justine Attal  2 , Martine Delannes  2 , Eric Huyghe  4   5 , Anne Ducassou  2
Affiliations

Assessment of an onco-sexology support and follow-up program in cervical or vaginal cancer patients undergoing brachytherapy

Marce-Amara Kpoghomou et al. Support Care Cancer. 2021 Aug.

Abstract

Purpose: Women's sexual health and wellbeing with cervical or vaginal cancer may be largely affected by complications from external beam radiotherapy (EBRT) and utero-vaginal brachytherapy (BT), of which vaginal stenosis is the main complication. The objective of this study was to assess the impact of support by a nurse sexologist on sexuality, vaginal side-effects, and the quality of clinical follow-up in patients treated with brachytherapy for cervical or vaginal cancer.

Methods: We performed a retrospective study of the sexuality of women treated for cervical or vaginal cancer. Data from patients with cervical or vaginal cancer who underwent brachytherapy between 2013 and 2017 were collected at Institut Universitaire de Cancer de Toulouse-Oncopôle (IUCT-Oncopôle). Patients were divided into two groups: group A (intervention group) received support from a nurse sexologist and group B (control group) did not. The chi-square test and a logistic multivariate model were used for data analysis.

Results: A total of 156 patients were included in this study, including 57.7% who were followed by a nurse sexologist. We observed low compliance in using vaginal dilators after brachytherapy and/or radiotherapy over time regardless of the group, and patients' sexual activity was inadequately addressed. Information regarding the resumption of sexuality 2 months after treatment was missing in 1.1% of patients in group A and in 36.4% of patients in group B. Multivariate analysis showed that patients in group A had a lower risk of developing vaginal stenosis with OR crude = 0.5 (95% CI = 0.25-0.92) and OR adj. = 0.5 (95% CI = 0.26-1.09) compared with those in group B.

Conclusion: This retrospective study highlights the lack of information collected by physicians during follow-up concerning the sexuality of patients with cervical or vaginal cancer treated by EBRT and BT. The support offered by nurse sexologists in improving patients' sexual activity and reducing their physical side-effects such as vaginal stenosis is likely to be beneficial. A prospective study is currently being conducted to validate the present findings.

Keywords: Brachytherapy; Cancer; Cervical; Sexuality; Supportive care.

PubMed Disclaimer

References

    1. Waggoner SE (2003) Cervical cancer. Lancet 361(9376):2217–2225 - DOI
    1. Lewis DR, Chen HS, Cockburn MG, Wu XC, Stroup AM, Midthune DN, Zou Z, Krapcho MF, Miller DG, Feuer EJ (2017) Early estimates of SEER cancer incidence, 2014. Cancer 123(13):2524–2534 - DOI
    1. Campanholo VM et al (2014) 765 g>c polymorphism of the cox-2 gene and gastric cancer risk in Brazilian population. Arq Gastroenterol 51(2):79–83 - DOI
    1. Wang N, Yang J, Lu J, Qiao Q, Bao G, Wu T, He X (2014) IL-17 gene polymorphism is associated with susceptibility to gastric cancer. Tumour Biol 35(10):10025–10030 - DOI
    1. Hidaka A, Sasazuki S, Goto A, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Inoue M, Noda M, Tajiri H, Tsugane S, for the JPHC Study Group (2015) Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Int J Cancer 136(6):1402–1410 - DOI

MeSH terms

LinkOut - more resources